
Voyager Biomedical develops VenaSure, a porous titanium implant designed to give hemodialysis patients reliable vascular access.
Voyager Biomedical is a medical device company whose business centers on the VenaSure vascular access implant. Hemodialysis depends on reliable vein access, and cannulation can be difficult, often requiring multiple needle attempts that risk injury, so the company built VenaSure to give cannulators a palpable target for fistula access.
VenaSure is a porous titanium scaffold, implanted in a short surgical procedure, that integrates with tissue and supports the vein while its bottom part is built to stop deep needle infiltration that can cause infection, blood loss, and fistula damage. Its two-part design separates as the vein enlarges, and the device is offered in multiple diameters to standardize cannulation across dialysis centers, including home dialysis.
Nanovasc
nanovasc.com

VenoStent
venostent.com

Venova Medical
venovamed.com

Access Vascular
Venarum Medical
Alucent Biomedical
alucentmedical.com

Healionics
healionics.com

Avenu Medical
avenumedical.com

Flex Vascular
flexvascular.com

Phraxis
phraxis.com

Solinas Medical
solinasmedical.com

Versago Vascular Access
Bioconnect Systems

Bluegrass Vascular Technologies
Vasca

Vascular Therapies
vasculartx.com

Vivifi Medical
vivifimedical.com

ATTWILL Vascular Technologies

enVVeno Medical
envveno.com

Forge Medical
forgemedical.com
Companies similar to Voyager Biomedical include Nanovasc, VenoStent, Venova Medical and Access Vascular.
Voyager Biomedical was founded in 2016.
Voyager Biomedical's headquarters is located in Houston, TX, US.
Voyager Biomedical's most recent funding round was for $5.8M (USD) in March 2025.
As of Mar 21, 2025, Voyager Biomedical has disclosed funding of $5.8M (USD).
Voyager Biomedical has 6 employees as of Feb 5, 2024.